CBT401

N/A

Report date: 2025/12/24 11:17:12
NME

Base Information

Drug NameCBT401
Drug Alias NameCBT-401CBT401
ClassificationSmall molecules
Mechanisms of ActionCreatine replacements
TargetsCreatine kinase
Therapy Area/IndicationsGlucose transporter type 1 deficiency syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCERES BRAIN Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCERES BRAIN Therapeutics
Inactive CompaniesN/A
Active IndicationsGlucose transporter type 1 deficiency syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A